Alpha-synuclein misfolding as fluid biomarker for Parkinson’s disease measured with the iRS platform | EMBO Molecular Medicine

imageimageA new fluid biomarker for Parkinson’s disease (PD) was developed, offering a high-accuracy biological classification, potentially at early stages. A discovery and a validation cohort consisting of 134 individuals was analyzed, using α-…

Read the full article here

Related Articles